KETOCONAZOLE
- Product NDC
- 71335-1652
- 11-digit product format
- 713351652
- Labeler code
- 71335
- Product ID
- 71335-1652_ad97ec3a-f51c-484b-87ec-8b3fb7a55089
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- KETOCONAZOLE
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Bryant Ranch Prepack
- Application
- ANDA210457
- Marketing category
- ANDA
- Marketing start
- 2018-06-26
- Marketing end
- 0000-00-00
- Substance
- KETOCONAZOLE
- Active strength
- 200 mg/1
- Pharmacologic classes
- Azole Antifungal [EPC],Azoles [CS],Cytochrome P450 3A4 Inhibitors [MoA],Cytochrome P450 3A5 Inhibitors [MoA],P-Glycoprotein Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2021-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 71335-1652-1 | 71335165201 | 10 TABLET in 1 BOTTLE (71335-1652-1) | 10 tablet | 2020-06-26 | 0000-00-00 | No | No | Current |
| 71335-1652-2 | 71335165202 | 30 TABLET in 1 BOTTLE (71335-1652-2) | 30 tablet | 2020-06-26 | 0000-00-00 | No | No | Current |
| 71335-1652-3 | 71335165203 | 40 TABLET in 1 BOTTLE (71335-1652-3) | 40 tablet | 2020-06-26 | 0000-00-00 | No | No | Current |
| 71335-1652-4 | 71335165204 | 60 TABLET in 1 BOTTLE (71335-1652-4) | 60 tablet | 2020-06-26 | 0000-00-00 | No | No | Current |
| 71335-1652-5 | 71335165205 | 8 TABLET in 1 BOTTLE (71335-1652-5) | 8 tablet | 2020-06-26 | 0000-00-00 | No | No | Current |
| 71335-1652-6 | 71335165206 | 7 TABLET in 1 BOTTLE (71335-1652-6) | 7 tablet | 2020-06-26 | 0000-00-00 | No | No | Current |
| 71335-1652-7 | 71335165207 | 14 TABLET in 1 BOTTLE (71335-1652-7) | 14 tablet | 2020-06-26 | 0000-00-00 | No | No | Current |
| 71335-1652-8 | 71335165208 | 90 TABLET in 1 BOTTLE (71335-1652-8) | 90 tablet | 2020-06-26 | 0000-00-00 | No | No | Current |